Author Archives: Mark Senak

Weekly Roundup 11.9.18

So much to talk about, so little time. The election (thankfully) is over. The days are shorter, darker, wetter and altogether more lean. Thanksgiving is but a few short weeks away and Christmas decorations are already sneaking their way into … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 11.9.18

Weekly Roundup 11.2.18

We are shifting gears as we head into the year’s end, with two months to wrap everything up and we kick it off by ending Daylight Saving 2018 this weekend – so remember to set your clocks back (Fall Back) … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 11.2.18

Weekly Roundup 10.26.18

A Nor’easter heads to the Nor’east. Autumn colors are appearing a bit tardy and a bit muted. There are many little people in costumes. And already Christmas decor can be spotted in shops, to which one must turn a blind … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 10.26.18

Weekly Roundup 10.19.18

Fall is in the air, election ads are on the air – it is definitely October, the time of trick or treat. Mums and pumpkins have replaced summer stock on front porches and in yards. Thanksgiving foods are on display … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 10.19.18

Speaking of Communications – OPDP on the Move

Over the past few years, regulatory action letters from FDA’s Office of Prescription Drug Promotion (OPDP), while once plentiful, has been something of a rare occurrence. In response to questions on the matter, FDA was often vague. This week however, … Continue reading

Posted in FDA Policy, Warning Letters | 2 Comments